IC
THRD

Ikarian Capital’s Third Harmonic Bio THRD Stock Holding History

Ikarian Capital’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-100,000
Closed -$347K – 187
2025
Q1 		$347K Hold
100,000
– – 0.04% 124
2024
Q4 		$1.03M Buy
+100,000
New +$1.25M 0.14% 107

Other funds holding THRD

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Ikarian Capital's THRD Position: Q2 2025 in Review

Ikarian Capital sold out of Third Harmonic Bio (THRD) in Q2 2025, closing a stake of 100,000 shares — an estimated $347K sold.

Ikarian Capital first reported a position in THRD in Q4 2024 and held it in 2 quarters. The position peaked at $1.03M in Q4 2024. 105 funds tracked by Wall St. Rank hold THRD as of Q2 2025.

  • Ikarian Capital reported no remaining Third Harmonic Bio position as of Q2 2025 after selling out during the quarter.
  • Ikarian Capital sold 100,000 Third Harmonic Bio shares in Q2 2025, an estimated $347K.
  • Ikarian Capital first reported a position in Third Harmonic Bio in Q4 2024 and held it in 2 quarters.
  • Ikarian Capital's Third Harmonic Bio position peaked at $1.03M in Q4 2024.
  • 105 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q2 2025.

Based on Ikarian Capital's 13F filing for Q2 2025, filed 14 Aug 2025.